{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:34:47Z","timestamp":1788374087704,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-025-01626-8","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:01:00Z","timestamp":1759230060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of antibacterial and antibiofilm efficacy of gentamicin-loaded solid lipid nanoparticles (GM-SLNs) against Acinetobacter baumannii infections"],"prefix":"10.1186","volume":"19","author":[{"given":"Mohsen","family":"Nazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-504X","authenticated-orcid":false,"given":"Seyed Mostafa","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"10204","key":"1626_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145\u201358.","journal-title":"Lancet"},{"key":"1626_CR2","unstructured":"Collaborators A. Articles Global burden of bacterial antimicrobial resistance in 2019? A systematic analysis. 399. 2022."},{"issue":"7","key":"1626_CR3","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1080\/09603123.2021.1892036","volume":"32","author":"M Nazari","year":"2022","unstructured":"Nazari M, Azizi O, Solgi H, Fereshteh S, Shokouhi S, Badmasti F. Emergence of carbapenem resistant Acinetobacter baumannii clonal complexes CC2 and CC10 among fecal carriages in an educational hospital. Int J Environ Health Res. 2022;32(7):1478\u201388.","journal-title":"Int J Environ Health Res"},{"issue":"5","key":"1626_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/500202","volume":"42","author":"PE Fournier","year":"2006","unstructured":"Fournier PE, Richet H, Weinstein RA. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1626_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.12998\/wjcc.v2.i12.787","volume":"2","author":"M-F Lin","year":"2014","unstructured":"Lin M-F, Lan C-Y. Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside. World J Clin Cases: WJCC. 2014;2(12):787.","journal-title":"World J Clin Cases: WJCC"},{"issue":"9","key":"1626_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jfma.2011.07.004","volume":"110","author":"H-C Chang","year":"2011","unstructured":"Chang H-C, Chen Y-C, Lin M-C, Liu S-F, Chung Y-H, Su M-C, et al. Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia. J Formos Med Assoc. 2011;110(9):564\u201371.","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"1626_CR7","doi-asserted-by":"publisher","first-page":"e0234684","DOI":"10.1371\/journal.pone.0234684","volume":"15","author":"P Cornejo-Ju\u00e1rez","year":"2020","unstructured":"Cornejo-Ju\u00e1rez P, Cevallos MA, Castro-Jaimes S, Castillo-Ram\u00edrez S, Vel\u00e1zquez-Acosta C, Mart\u00ednez-Oliva D, et al. High mortality in an outbreak of multidrug resistant Acinetobacter baumannii infection introduced to an oncological hospital by a patient transferred from a general hospital. PLoS ONE. 2020;15(7):e0234684.","journal-title":"PLoS ONE"},{"issue":"1","key":"1626_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/ijmm.IJMM_19_492","volume":"38","author":"AO John","year":"2020","unstructured":"John AO, Paul H, Vijayakumar S, Anandan S, Sudarsan T, Abraham OC, et al. Mortality from acinetobacter infections as compared to other infections among critically ill patients in South india: A prospective cohort study. Ind J Med Microbiol. 2020;38(1):24\u201332.","journal-title":"Ind J Med Microbiol"},{"issue":"1","key":"1626_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12879-022-07436-w","volume":"22","author":"A Vivo","year":"2022","unstructured":"Vivo A, Fitzpatrick MA, Suda KJ, Jones MM, Perencevich EN, Rubin MA, et al. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study. BMC Infect Dis. 2022;22(1):491.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1626_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/antibiotics11081086","volume":"11","author":"D Alrahmany","year":"2022","unstructured":"Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM. Acinetobacter baumannii infection-related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions. Antibiotics. 2022;11(8):1086.","journal-title":"Antibiotics"},{"key":"1626_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1874285801610010032","volume":"10","author":"M Pourhajibagher","year":"2016","unstructured":"Pourhajibagher M, Hashemi FB, Pourakbari B, Aziemzadeh M, Bahador A. Antimicrobial resistance of Acinetobacter baumannii to Imipenem in iran: a systematic review and meta-analysis. Open Microbiol J. 2016;10:32.","journal-title":"Open Microbiol J"},{"issue":"2","key":"1626_CR12","first-page":"115","volume":"32","author":"S Tahbaz","year":"2019","unstructured":"Tahbaz S, Azimi L, Lari A. Characterization of aminoglycoside resistance mechanisms in Acinetobacter baumannii isolates from burn wound colonization. Ann Burns Fire Disasters. 2019;32(2):115.","journal-title":"Ann Burns Fire Disasters"},{"key":"1626_CR13","doi-asserted-by":"crossref","unstructured":"Gedefie A, Demsis W, Ashagrie M, Kassa Y, Tesfaye M, Tilahun M et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect Drug Resist. 2021:3711\u20139.","DOI":"10.2147\/IDR.S332051"},{"issue":"1","key":"1626_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13353-023-00811-6","volume":"65","author":"J Hemmati","year":"2024","unstructured":"Hemmati J, Nazari M, Ahmadi A, Bayati M, Jalili M, Taheri M, et al. In vitro evaluation of biofilm phenotypic and genotypic characteristics among clinical isolates of Pseudomonas aeruginosa in Hamadan, West of Iran. J Appl Genet. 2024;65(1):213\u201322.","journal-title":"J Appl Genet"},{"key":"1626_CR15","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez\u2010Ba\u00f1o J, Marti S, Soto S, Fern\u00e1ndez\u2010Cuenca F, Cisneros JM, Pach\u00f3n J, Pascual A, Mart\u00ednez\u2010Mart\u00ednez L, McQueary C, Actis LA, Vila J. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2018;14(3):276\u20138.","DOI":"10.1111\/j.1469-0691.2007.01916.x"},{"issue":"6","key":"1626_CR16","first-page":"396","volume":"20","author":"P Poorzargar","year":"2017","unstructured":"Poorzargar P, Javadpour S, Karmostaji A. Distribution and antibiogram pattern of acinetobacter infections in Shahid Mohammadi hospital, Bandar Abbas, Iran. Hormozgan Med J. 2017;20(6):396\u2013403.","journal-title":"Hormozgan Med J"},{"key":"1626_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fcimb.2020.00253","volume":"10","author":"JM Colquhoun","year":"2020","unstructured":"Colquhoun JM, Rather PN. Insights into mechanisms of biofilm formation in Acinetobacter baumannii and implications for uropathogenesis. Front Cell Infect Microbiol. 2020;10:253.","journal-title":"Front Cell Infect Microbiol"},{"key":"1626_CR18","doi-asserted-by":"crossref","unstructured":"Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infection and drug resistance. 2018:2277\u201399.","DOI":"10.2147\/IDR.S169894"},{"issue":"2","key":"1626_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/pr400603f","volume":"13","author":"CM Gayoso","year":"2014","unstructured":"Gayoso CM, Mateos Js, M\u00e9ndez JA, Fern\u00e1ndez-Puente P, Rumbo C, Tomas M, et al. Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J Proteome Res. 2014;13(2):460\u201376.","journal-title":"J Proteome Res"},{"issue":"11","key":"1626_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/antibiotics9110817","volume":"9","author":"AM Shenkutie","year":"2020","unstructured":"Shenkutie AM, Yao MZ, Siu GK-h, Wong BKC. Leung PH-m. Biofilm-induced antibiotic resistance in clinical Acinetobacter baumannii isolates. Antibiotics. 2020;9(11):817.","journal-title":"Antibiotics"},{"key":"1626_CR21","doi-asserted-by":"publisher","first-page":"793615","DOI":"10.3389\/fmed.2022.793615","volume":"9","author":"S Roy","year":"2022","unstructured":"Roy S, Chowdhury G, Mukhopadhyay AK, Dutta S, Basu S. Convergence of biofilm formation and antibiotic resistance in Acinetobacter baumannii infection. Front Med. 2022;9:793615.","journal-title":"Front Med"},{"key":"1626_CR22","doi-asserted-by":"publisher","first-page":"116433","DOI":"10.1016\/j.biopha.2024.116433","volume":"174","author":"MR Arabestani","year":"2024","unstructured":"Arabestani MR, Bigham A, Kamarehei F, Dini M, Gorjikhah F, Shariati A, et al. Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases. Biomed Pharmacother. 2024;174:116433.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1626_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40262-022-01143-0","volume":"61","author":"CJ Hodiamont","year":"2022","unstructured":"Hodiamont CJ, van den Broek AK, de Vroom SL, Prins JM, Math\u00f4t RA, van Hest RM. Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for gram-negative infections: an updated review. Clin Pharmacokinet. 2022;61(8):1075\u201394.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"1626_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/nano11051251","volume":"11","author":"L Arana","year":"2021","unstructured":"Arana L, Gallego L, Alkorta I. Incorporation of antibiotics into solid lipid nanoparticles: a promising approach to reduce antibiotic resistance emergence. Nanomaterials. 2021;11(5):1251.","journal-title":"Nanomaterials"},{"issue":"5","key":"1626_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332.","journal-title":"Am J Infect Control"},{"issue":"6","key":"1626_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1099\/jmm.0.000987","volume":"68","author":"SS Abhari","year":"2019","unstructured":"Abhari SS, Badmasti F, Modiri L, Aslani MM, Asmar M. Circulation of imipenem-resistant Acinetobacter baumannii ST10, ST2 and ST3 in a university teaching hospital from Tehran, Iran. J Med Microbiol. 2019;68(6):860\u20135.","journal-title":"J Med Microbiol"},{"issue":"2","key":"1626_CR27","first-page":"54","volume":"1","author":"H Goudarzi","year":"2013","unstructured":"Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment of antibiotic resistance pattern in Acinetobacter bumannii carrying Bla OxA type genes isolated from hospitalized patients. Novelty Biomed. 2013;1(2):54\u201361.","journal-title":"Novelty Biomed"},{"key":"1626_CR28","doi-asserted-by":"crossref","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. 2024:ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"1626_CR29","doi-asserted-by":"publisher","first-page":"fmed-12","DOI":"10.3389\/fmed.2025.1527662","volume":"12","author":"M Nazari","year":"2025","unstructured":"Nazari M, Alikhani MS, Hemmati J, Ahmadi A, Hashemi SH, Alikhani MY. Exploring fluoroquinolone resistance mechanisms and the effects of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) in Acinetobacter baumannii. Front Med. 2025;12:fmed-12.","journal-title":"Front Med"},{"issue":"1","key":"1626_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12941-024-00760-w","volume":"23","author":"M Nazari","year":"2024","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY. The antimicrobial and antibiofilm effects of gentamicin, imipenem, and fucoidan combinations against dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii isolated from diabetic foot ulcers. Ann Clin Microbiol Antimicrob. 2024;23(1):101.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1626_CR31","doi-asserted-by":"publisher","first-page":"1030401","DOI":"10.3389\/fmicb.2023.1030401","volume":"14","author":"R Mirzaei","year":"2023","unstructured":"Mirzaei R, Esmaeili Gouvarchin Ghaleh H, Ranjbar R. Antibiofilm effect of Melittin alone and in combination with conventional antibiotics toward strong biofilm of MDR-MRSA and -Pseudomonas aeruginosa. Front Microbiol. 2023;14:1030401.","journal-title":"Front Microbiol"},{"issue":"1","key":"1626_CR32","doi-asserted-by":"publisher","first-page":"1403019","DOI":"10.1155\/cjid\/1403019","volume":"2024","author":"M Nazari","year":"2024","unstructured":"Nazari M, Hemmati J, Asghari B. Comprehensive analysis of virulence genes, antibiotic resistance, biofilm formation, and sequence types in clinical isolates of Klebsiella pneumoniae. Can J Infect Dis Med Microbiol. 2024;2024(1):1403019.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1626_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s12011-019-01798-0","volume":"194","author":"SM Hosseini","year":"2020","unstructured":"Hosseini SM, Farmany A, Arabestani MR. Effect of doxycycline-loaded solid lipid nanoparticles on serum level of trace elements, biochemical and hematological parameters in acute and chronic brucellosis. Biol Trace Elem Res. 2020;194:463\u201371.","journal-title":"Biol Trace Elem Res"},{"key":"1626_CR34","doi-asserted-by":"publisher","first-page":"890252","DOI":"10.3389\/fchem.2022.890252","volume":"10","author":"SM Hosseini","year":"2022","unstructured":"Hosseini SM, Farmany A, Alikhani MY, Taheri M, Asl SS, Alamian S, et al. Co-delivery of Doxycycline and hydroxychloroquine using CdTe-labeled solid lipid nanoparticles for treatment of acute and chronic brucellosis. Front Chem. 2022;10:890252.","journal-title":"Front Chem"},{"issue":"1","key":"1626_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1128\/JCM.41.1.403-409.2003","volume":"41","author":"A Espinel-Ingroff","year":"2003","unstructured":"Espinel-Ingroff A. Evaluation of broth microdilution testing parameters and agar diffusion etest procedure for testing susceptibilities of Aspergillus spp. To Caspofungin acetate (MK-0991). J Clin Microbiol. 2003;41(1):403\u20139.","journal-title":"J Clin Microbiol"},{"key":"1626_CR36","unstructured":"Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 2011."},{"key":"1626_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10096-018-3189-7","volume":"37","author":"AM Bardbari","year":"2018","unstructured":"Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, et al. Highly synergistic activity of Melittin with Imipenem and colistin in biofilm Inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 2018;37:443\u201354.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1626_CR38","doi-asserted-by":"publisher","first-page":"112670","DOI":"10.1016\/j.biopha.2022.112670","volume":"147","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Alikhani MY, Arciola CR, Sedighi I, Yousefimashouf R, Bagheri KP. Prevention, inhibition, and degradation effects of Melittin alone and in combination with Vancomycin and Rifampin against strong biofilm producer strains of methicillin-resistant Staphylococcus epidermidis. Biomed Pharmacother. 2022;147:112670.","journal-title":"Biomed Pharmacother"},{"key":"1626_CR39","doi-asserted-by":"publisher","first-page":"631426","DOI":"10.3389\/fmicb.2021.631426","volume":"12","author":"BT Birhanu","year":"2021","unstructured":"Birhanu BT, Lee EB, Lee SJ, Park SC. Targeting Salmonella typhimurium invasion and intracellular survival using pyrogallol. Front Microbiol. 2021;12:631426.","journal-title":"Front Microbiol"},{"key":"1626_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10989-018-9675-z","volume":"25","author":"R Shams Khozani","year":"2019","unstructured":"Shams Khozani R, Shahbazzadeh D, Harzandi N, Feizabadi MM, Pooshang Bagheri K. Kinetics study of antimicrobial peptide, melittin, in simultaneous biofilm degradation and eradication of potent biofilm producing MDR Pseudomonas aeruginosa isolates. Int J Pept Res Ther. 2019;25:329\u201338.","journal-title":"Int J Pept Res Ther"},{"key":"1626_CR41","doi-asserted-by":"publisher","first-page":"101357","DOI":"10.1016\/j.genrep.2021.101357","volume":"25","author":"Z Akhgari","year":"2021","unstructured":"Akhgari Z, Nazari R, Zargar M, Tanomand A. Antibacterial and antibiofilm properties of acroptilon repens (L.) Dc extract and its effect on exotoxin A gene expression of Pseudomonas aeruginosa. Gene Rep. 2021;25:101357.","journal-title":"Gene Rep"},{"issue":"1","key":"1626_CR42","first-page":"62","volume":"5","author":"O Azizi","year":"2016","unstructured":"Azizi O, Shahcheraghi F, Salimizand H, Modarresi F, Shakibaie MR, Mansouri S, et al. Molecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant acinetobacter baumannii. Rep Biochem Mol Biol. 2016;5(1):62.","journal-title":"Rep Biochem Mol Biol"},{"key":"1626_CR43","doi-asserted-by":"crossref","unstructured":"Nazari M, Taheri M, Nouri F, Bahmanzadeh M, Alikhani MY. Time-kill curve analysis of fucoidan combination with conventional antibiotics against biofilms formation of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii clinical isolates. Chemotherapy. 2024:1\u201312.","DOI":"10.1159\/000542826"},{"issue":"1","key":"1626_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40001-024-02255-y","volume":"30","author":"M Nazari","year":"2025","unstructured":"Nazari M, Shokoohizadeh L, Taheri M. Natural products in the treatment of diabetic foot infection. Eur J Med Res. 2025;30(1):8.","journal-title":"Eur J Med Res"},{"issue":"9","key":"1626_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/antibiotics13090880","volume":"13","author":"V Aleksic Sabo","year":"2024","unstructured":"Aleksic Sabo V, \u0160kori\u0107 D, Jovanovi\u0107-\u0160anta S, Knezevic P. Exploring biofilm-related traits and bile salt efficacy as Anti-Biofilm agents in MDR Acinetobacter baumannii. Antibiotics. 2024;13(9):880.","journal-title":"Antibiotics"},{"issue":"5","key":"1626_CR46","first-page":"203","volume":"30","author":"HN Pham","year":"2024","unstructured":"Pham HN, Than TDN, Nguyen HA, Vu DH, Phung TH, Nguyen TK. Antibiotic resistance, biofilm formation, and persistent phenotype of Klebsiella pneumoniae in a Vietnamese tertiary hospital: a focus on Amikacin. Microb Drug Resist. 2024;30(5):203\u20139.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"1626_CR47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antibiotics12020328","volume":"12","author":"C Michaelis","year":"2023","unstructured":"Michaelis C, Grohmann E. Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiotics. 2023;12(2):328.","journal-title":"Antibiotics"},{"key":"1626_CR48","doi-asserted-by":"crossref","unstructured":"Alara JA, Alara OR. An overview of the global alarming increase of multiple drug resistant: a major challenge in clinical diagnosis. Infect Disorders-Drug Targets (Formerly Curr Drug Targets-Infectious Disorders). 2024;24(3):26\u201342.","DOI":"10.2174\/1871526523666230725103902"},{"key":"1626_CR49","doi-asserted-by":"publisher","first-page":"122739","DOI":"10.1016\/j.ijpharm.2023.122739","volume":"635","author":"C Vairo","year":"2023","unstructured":"Vairo C, Vidal MV, Hernandez RM, Igartua M, Villullas S. Colistin-and Amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections. Int J Pharm. 2023;635:122739.","journal-title":"Int J Pharm"},{"key":"1626_CR50","doi-asserted-by":"publisher","first-page":"112938","DOI":"10.1016\/j.jim.2020.112938","volume":"488","author":"H Afshari","year":"2021","unstructured":"Afshari H, Maleki M, Hakimian M, Tanha RA, Salouti M. Immunogenicity evaluating of the SLNs-alginate conjugate against Pseudomonas aeruginosa. J Immunol Methods. 2021;488:112938.","journal-title":"J Immunol Methods"},{"key":"1626_CR51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejpb.2018.11.017","volume":"134","author":"A Gonz\u00e1lez-Paredes","year":"2019","unstructured":"Gonz\u00e1lez-Paredes A, Sitia L, Ruyra A, Morris CJ, Wheeler GN, McArthur M, et al. Solid lipid nanoparticles for the delivery of anti-microbial oligonucleotides. Eur J Pharm Biopharm. 2019;134:166\u201377.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"1626_CR52","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1111\/1750-3841.15732","volume":"86","author":"M Alanchari","year":"2021","unstructured":"Alanchari M, Mohammadi M, Yazdian F, Ahangari H, Ahmadi N, Emam-Djomeh Z, et al. Optimization and antimicrobial efficacy of Curcumin loaded solid lipid nanoparticles against foodborne bacteria in hamburger patty. J Food Sci. 2021;86(6):2242\u201354.","journal-title":"J Food Sci"},{"issue":"3","key":"1626_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1208\/s12249-019-1337-8","volume":"20","author":"S Talegaonkar","year":"2019","unstructured":"Talegaonkar S, Bhattacharyya A. Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability. AAPS PharmSciTech. 2019;20(3):121.","journal-title":"AAPS PharmSciTech"},{"key":"1626_CR54","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1007\/s13346-021-00921-w","volume":"11","author":"CR Thorn","year":"2021","unstructured":"Thorn CR, Thomas N, Boyd BJ, Prestidge CA. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy. Drug Delivery Transl Res. 2021;11:1598\u2013624.","journal-title":"Drug Delivery Transl Res"},{"key":"1626_CR55","doi-asserted-by":"publisher","first-page":"e1296","DOI":"10.31661\/gmj.v8i0.1296","volume":"8","author":"A Razei","year":"2019","unstructured":"Razei A, Cheraghali AM, Saadati M, Ramandi MF, Panahi Y, Hajizade A, et al. Gentamicin-loaded Chitosan nanoparticles improve its therapeutic effects on brucella-infected J774A.1 murine cells. Galen Med J. 2019;8:e1296.","journal-title":"Galen Med J"},{"issue":"sup6","key":"1626_CR56","doi-asserted-by":"publisher","first-page":"B96","DOI":"10.1179\/1753555714Y.0000000194","volume":"30","author":"Y Li","year":"2015","unstructured":"Li Y, Liu L, Qu X, Ren L, Dai K. Drug delivery property, antibacterial performance and cytocompatibility of gentamicin loaded Poly (lactic-co-glycolic acid) coating on porous magnesium scaffold. Mater Technol. 2015;30(sup6):B96\u2013103.","journal-title":"Mater Technol"},{"issue":"4","key":"1626_CR57","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/infdis\/171.4.938","volume":"171","author":"IA Bakker-Woudenberg","year":"1995","unstructured":"Bakker-Woudenberg IA, Ten Kate M, Stearne-Cullen L, Woodle M. Efficacy of gentamicin or Ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis. 1995;171(4):938\u201347.","journal-title":"J Infect Dis"},{"key":"1626_CR58","doi-asserted-by":"crossref","unstructured":"Wu Z-L, Zhao J, Xu R. Recent advances in oral nano-antibiotics for bacterial infection therapy. Int J Nanomed. 2020:9587\u2013610.","DOI":"10.2147\/IJN.S279652"},{"issue":"4","key":"1626_CR59","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/138920012800166526","volume":"13","author":"J Qi","year":"2012","unstructured":"Qi J, Lu Y, Wu W. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles. Curr Drug Metab. 2012;13(4):418\u201328.","journal-title":"Curr Drug Metab"},{"key":"1626_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13346-020-00795-4","volume":"11","author":"MM Anjum","year":"2021","unstructured":"Anjum MM, Patel KK, Dehari D, Pandey N, Tilak R, Agrawal AK, et al. Anacardic acid encapsulated solid lipid nanoparticles for Staphylococcus aureus biofilm therapy: Chitosan and DNase coating improves antimicrobial activity. Drug Delivery Transl Res. 2021;11:305\u201317.","journal-title":"Drug Delivery Translational Res"},{"key":"1626_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12247-020-09446-0","volume":"16","author":"H Akhtari","year":"2021","unstructured":"Akhtari H, Fazly Bazzaz BS, Golmohammadzadeh S, Movaffagh J, Soheili V, Khameneh B. Rifampin and cis-2-decenoic acid co-entrapment in solid lipid nanoparticles as an efficient nano-system with potent anti-biofilm activities. J Pharm Innov. 2021;16:293\u2013301.","journal-title":"J Pharm Innov"},{"key":"1626_CR62","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.micpath.2015.11.031","volume":"93","author":"BSF Bazzaz","year":"2016","unstructured":"Bazzaz BSF, Khameneh B, Zarei H, Golmohammadzadeh S. Antibacterial efficacy of Rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm. Microb Pathog. 2016;93:137\u201344.","journal-title":"Microb Pathog"},{"key":"1626_CR63","doi-asserted-by":"publisher","first-page":"114770","DOI":"10.1016\/j.addr.2023.114770","volume":"196","author":"H Han","year":"2023","unstructured":"Han H, Li S, Xu M, Zhong Y, Fan W, Xu J, et al. Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives. Adv Drug Deliv Rev. 2023;196:114770.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1626_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1381612820666140905123529","volume":"21","author":"C Martin","year":"2015","unstructured":"Martin C, LiLow W, Gupta A, Cairul Iqbal Mohd Amin M, Radecka I, Britland T. Strategies for antimicrobial drug delivery to biofilm. Curr Pharm Design. 2015;21(1):43\u201366.","journal-title":"Curr Pharm Design"},{"issue":"3","key":"1626_CR65","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/pharmaceutics16030396","volume":"16","author":"A Ahsan","year":"2024","unstructured":"Ahsan A, Thomas N, Barnes TJ, Subramaniam S, Loh TC, Joyce P, et al. Lipid nanocarriers-enabled delivery of antibiotics and antimicrobial adjuvants to overcome bacterial biofilms. Pharmaceutics. 2024;16(3):396.","journal-title":"Pharmaceutics"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01626-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01626-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01626-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:07:22Z","timestamp":1759234042000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01626-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01626-8","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Hamadan University of Medical Sciences (IR.UMSHA.REC.1404.197). As the research was conducted solely on bacterial isolates without human participants, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}